Groowe Groowe / Newsroom / INO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

INO News

Inovio Pharmaceuticals, Inc.

Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm

globenewswire.com
INO

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

prnewswire.com
INO

Form 8-K

sec.gov
INO

Form 8-K

sec.gov
INO

INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

prnewswire.com
INO

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
INO REGN VIR MRK AMGN ABT QGEN BDX TMO DHR MYGN ILMN EXAS BIO

INOVIO to Participate in Upcoming Scientific Conferences

prnewswire.com
INO

Lifshitz Law PLLC Announces Investigations of Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), Oracle Corporation (NYSE: ORCL), and BlackRock, TCP Capital Corp. (NASDAQ: TCPC)

accessnewswire.com
INO RARE ORCL TCPC

Lifshitz Law PLLC Announces Investigations of REGENXBIO Inc. (NASDAQ: RGNX), Kyndryl Holdings, Inc. (NYSE: KD), Inovio Pharmaceuticals, Inc. (NASDAQ: INO), and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)

accessnewswire.com
RGNX KD INO RARE

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

globenewswire.com
INO